Literature DB >> 9814968

Intracellular signaling leads to the hypertrophic effect of neuropeptide Y.

Y Goldberg1, G Taimor, H M Piper, K D Schlüter.   

Abstract

Signal transduction pathways involved in the hypertrophic effect of neuropeptide Y (NPY) were investigated in adult cardiomyocytes. Reduction of transforming growth factor-beta activity in serum-supplemented media abolished the induction of hypertrophic responsiveness to NPY. In responsive cells, NPY (100 nM) increased protein synthesis, determined as incorporation of [14C]phenylalanine, by 35 +/- 15% (P < 0.05, n = 16 cultures). In these cells, NPY activated pertussis toxin (PTx)-sensitive G proteins and phosphatidylinositol (PI) 3-kinase. PTx and inhibition of PI 3-kinase abolished the hypertrophic effect of NPY. NPY also activated protein kinase C (PKC) and mitogen-activated protein (MAP) kinase. Inhibition of these two kinases attenuated the induction of creatine kinase (CK)-BB but not the growth response to NPY. In conclusion, NPY stimulates protein synthesis in adult cardiomyocytes via activation of PTx-sensitive G proteins and PI 3-kinase and it induces the fetal-type CK-BB via activation of PKC and MAP kinase.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9814968     DOI: 10.1152/ajpcell.1998.275.5.C1207

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  10 in total

1.  Inhibitory effect of D1-like dopamine receptors on neuropeptide Y-induced proliferation in vascular smooth muscle cells.

Authors:  Yongqiao Zhou; Weibin Shi; Hao Luo; Rongchuan Yue; Zhen Wang; Wei Wang; Li Liu; Wei Eric Wang; Hongyong Wang; Chunyu Zeng
Journal:  Hypertens Res       Date:  2015-07-16       Impact factor: 3.872

2.  Neuropeptide Y reduces the expression of PLCB2, PLCD1 and selected PLC genes in cultured human endothelial cells.

Authors:  V R Lo Vasco; M Leopizzi; C Puggioni; C Della Rocca; R Businaro
Journal:  Mol Cell Biochem       Date:  2014-06-06       Impact factor: 3.396

3.  Glial-derived neurotrophic factor modulates enteric neuronal survival and proliferation through neuropeptide Y.

Authors:  Mallappa Anitha; Bindu Chandrasekharan; Joana R Salgado; Eric Grouzmann; Simon Mwangi; Shanthi V Sitaraman; Shanthi Srinivasan
Journal:  Gastroenterology       Date:  2006-07-24       Impact factor: 22.682

4.  Neuropeptide Y (NPY) potentiates phenylephrine-induced mitogen-activated protein kinase activation in primary cardiomyocytes via NPY Y5 receptors.

Authors:  C Pellieux; T Sauthier; A Domenighetti; D J Marsh; R D Palmiter; H R Brunner; T Pedrazzini
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

5.  Neuropeptide Y increases 4-aminopyridine-sensitive transient outward potassium current in rat ventricular myocytes.

Authors:  M P Heredia; M Fernández-Velasco; G Benito; C Delgado
Journal:  Br J Pharmacol       Date:  2002-04       Impact factor: 8.739

6.  Deletion of neuropeptide Y (NPY) 2 receptor in mice results in blockage of NPY-induced angiogenesis and delayed wound healing.

Authors:  A Jonas Ekstrand; Renhai Cao; Meit Bjorndahl; Susanne Nystrom; Ann-Cathrine Jonsson-Rylander; Hessameh Hassani; Bengt Hallberg; Margareta Nordlander; Yihai Cao
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-02       Impact factor: 11.205

7.  Neuropeptide Y promotes TGF-beta1 production in RAW264.7 cells by activating PI3K pathway via Y1 receptor.

Authors:  Jiang-Rui Zhou; Zheng Xu; Chun-Lei Jiang
Journal:  Neurosci Bull       Date:  2008-06       Impact factor: 5.203

Review 8.  The homeostatic role of neuropeptide Y in immune function and its impact on mood and behaviour.

Authors:  A Farzi; F Reichmann; P Holzer
Journal:  Acta Physiol (Oxf)       Date:  2015-01-09       Impact factor: 6.311

9.  Cancer induces cardiomyocyte remodeling and hypoinnervation in the left ventricle of the mouse heart.

Authors:  Christian Mühlfeld; Suman Kumar Das; Frank R Heinzel; Albrecht Schmidt; Heiner Post; Silvia Schauer; Tamara Papadakis; Wolfgang Kummer; Gerald Hoefler
Journal:  PLoS One       Date:  2011-05-26       Impact factor: 3.240

Review 10.  Peptide YY: more than just an appetite regulator.

Authors:  Shanta J Persaud; Gavin A Bewick
Journal:  Diabetologia       Date:  2014-06-11       Impact factor: 10.122

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.